...to Biotech Outsourcing Strategies Events
Launched in 2006 by Bio2Business Ltd, BOS Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs ; High Quality Content (delivered through the multistream programme); 1-to-1 Partnering (facilitated by partnering software made available to all delegates); Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!)

2020 GOLD SPONSORS

 

2020 EXHIBITION SPONSORS

 

2020 SILVER SPONSORS

Featured Speaker

photo of Dr Catherine Cancian

Working with CMOs to Develop a Robust Manufacturing Strategy for Recombinant Virus Vectors

Dr Catherine Cancian, VP Pharma Operations, Gensight Biologics

ABSTRACT: At GenSight Biologics, we have been working to accelerate cycle times and manage regulatory compliance from early development (preclinical to first- in- man) to commercial to provide to the patients beneficial solutions for counteracting the effect of rare and irreversible vision loss that can lead to legal blindness in very short time after the onset of the disease.

This presentation highlights the CMC strategy we have developed in the context of operational outsourcing to key suppliers including analytical, process development, manufacturing, and supply chain.

The execution part of a strategy is the critical and requires not only manufacturing capacities but also a successful integration of the process and analytical development sciences, the quality systems that apply to all aspects of GMP manufacturing and an acute understanding of the regulators expectations. All along our Pharmaceutical Development, we have been focusing on supplying in due time the... Click here to Read More

What's new

CALIXAR confirms Silver Sponsorship at BOS Basel 2020

Bio2Business is delighted to welcome CALIXAR as a SILVER Sponsor at BOS Basel 2020. CALIXAR has developed unique technologies coupled with a state-of-the-art research platform enabling the production of novel therapeutic targets of the highest quality and covering all therapeutic areas. In particular, CALIXAR uses its patented technology platform for other companies that need to identify, express, extract, purify and stabilize native membrane proteins (GPCRs, ion channels, receptors, transporters and viral targets).

Read more

Legacy Pharmaceuticals Switzerland GmbH Confirms Gold Sponsor Package in partnership with SCHOTT Pharmaceutical Systems at BOS Basel 2020

Legacy Pharmaceuticals, a global GMP-compliant contract manufacturer of sterile/aseptic in liquid and powder form and non-sterile semi-solid pharmaceutical products was founded in 1947. The company remains true to its Swiss origins and has built up a justified reputation for excellence, quality and reliability in the industry. FDA approved and globally active, the products Legacy manufacture on behalf of third parties are sold in 112 countries around the world including Japan, Russia, Korea to name a few.

Read more

CALIXAR confirms Silver Sponsorship at BOS Manchester 2020

Bio2Business is delighted to welcome CALIXAR as a SILVER Sponsor at BOS Manchester 2020. CALIXAR has developed unique technologies coupled with a state-of-the-art research platform enabling the production of novel therapeutic targets of the highest quality and covering all therapeutic areas. In particular, CALIXAR uses its patented technology platform for other companies that need to identify, express, extract, purify and stabilize native membrane proteins (GPCRs, ion channels, receptors, transporters and viral targets).

Read more

BOS Testimonials|2018                      BOS Testimonials|2019